Neumora Therapeutics, Inc. (NMRA)
Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
1. 7400
-0.01
-0.57%
$
344.63M Market Cap
- P/E Ratio
- Div Yield
647,339 Volume
-1.75 Eps
$ 1.75
Previous Close 
Want to track NMRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
NMRA Earnings Reports FAQ
What is the earnings per share (EPS) for NMRA?
The current EPS is -1.75.
What is the company's earnings growth rate?
Neumora Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Neumora Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Neumora Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for NMRA at this time, as Neumora Therapeutics, Inc has no recent EPS data to calculate it.
